GYS1 and breast cancer: Only high GYS1 mRNA expression was associated with worse patient overall survival in the entire breast cancer cohort (Fig. 1b, hazard ratio [HR] 1.20 (95% confidence interval [CI] 1.05–1.38), log-rank P = 0.009; Suppl.